Inotropic activity refers to the ability of a drug or substance to affect the contractility of cardiac muscle. It is commonly used to describe the positive or negative effects on the strength and force of heart contractions.
Positive inotropic activity refers to substances that enhance the strength of heart contractions. This can be achieved through various mechanisms, such as increasing calcium influx into cardiac cells, enhancing the release of calcium from intracellular stores, or inhibiting phosphodiesterase enzymes that break down cyclic adenosine monophosphate (cAMP), an important signaling molecule involved in cardiac contractility. Medications with positive inotropic effects, such as digoxin or beta-adrenergic agonists, are commonly used to treat conditions like heart failure or atrial fibrillation.
On the other hand, negative inotropic activity refers to substances that decrease the strength of heart contractions. This can be achieved through mechanisms such as blocking calcium influx into cardiac cells, inhibiting the release of calcium from intracellular stores, or decreasing the sensitivity of the cardiac myofilaments to calcium ions. Medications with negative inotropic effects, such as beta-blockers or calcium channel blockers, are used in conditions like hypertension or angina to lower heart rate and contractility.
Inotropic activity is an important concept in cardiology and is often considered when choosing appropriate medications for patients with cardiovascular conditions.
inotropic activity
1 answer